>
ReSearch Pharmaceutical Services Inc logo

RPSE - ReSearch Pharmaceutical Services Inc Share Price

n/a 0.0  0.0%

Last Trade -

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £199.9m
Position in Universe th / 6850
Bullish
Bearish
Unlock RPSE Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2004 2005 2006 2007 2008 2009 2010E 2011E CAGR / Avg
63.0 70.9 94.7 134.4 175.1 224.2 +28.9%
-37.3
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2010,Research Pharmaceutical Services, Inc revenues increased32% to $214.3M. Net income increased 75% to $3.5M. Revenuesreflect United States segment increase of 34% to $61.7M,Asia-Pecific segment increase from $492K to $1.1M. Netincome benefited from Other Income/ Expense decrease of 71%to $84K (expense). Basic Earnings per Share excludingExtraordinary Items increased from $0.05 to $0.09.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

RPSE Revenue Unlock RPSE Revenue

Net Income

RPSE Net Income Unlock RPSE Revenue

Normalised EPS

RPSE Normalised EPS Unlock RPSE Revenue

PE Ratio Range

RPSE PE Ratio Range Unlock RPSE Revenue

Dividend Yield Range

RPSE Dividend Yield Range Unlock RPSE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
RPSE EPS Forecasts Unlock RPSE Revenue
Profile Summary

ReSearch Pharmaceutical Services Inc. is a United States based company. The Company is a provider of outsourcing Clinical Development Solutions, provides Phase I-IV services. It provides a project based delivery solution with market full service processes and tools. Its embedded solutions are designed for pipeline portfolio management of large and mid-size customers. Its Hybrid solutions are designed for portfolio management of mid-sized customers. The Company’s full-service clinical outsourcing solutions are designed for project and program-level outsourcing.

Directors
Last Annual December 31st, 2009
Last Interim September 30th, 2010
Incorporated January 30, 2006
No. of Shareholders: 101
No. of Employees: 2,185
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Global Market
Shares in Issue 37,264,215
Free Float (0.0%)
Eligible for
ISAs
SIPPs
RPSE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for RPSE
Upcoming Events for RPSE
Frequently Asked Questions for ReSearch Pharmaceutical Services Inc
What is the ReSearch Pharmaceutical Services Inc share price?

As of , shares in ReSearch Pharmaceutical Services Inc are trading at n/a, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the ReSearch Pharmaceutical Services Inc share price performed this year?

Shares in ReSearch Pharmaceutical Services Inc are currently trading at n/a and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the ReSearch Pharmaceutical Services Inc price has moved by % over the past year.

What are the analyst and broker recommendations for ReSearch Pharmaceutical Services Inc?

There are no analysts currently covering ReSearch Pharmaceutical Services Inc.

When will ReSearch Pharmaceutical Services Inc next release its financial results?

ReSearch Pharmaceutical Services Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2011-09-30
What is the ReSearch Pharmaceutical Services Inc dividend yield?

ReSearch Pharmaceutical Services Inc does not currently pay a dividend.

Does ReSearch Pharmaceutical Services Inc pay a dividend?

ReSearch Pharmaceutical Services Inc does not currently pay a dividend.

When does ReSearch Pharmaceutical Services Inc next pay dividends?

ReSearch Pharmaceutical Services Inc does not currently pay a dividend.

How do I buy ReSearch Pharmaceutical Services Inc shares?

To buy shares in ReSearch Pharmaceutical Services Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of ReSearch Pharmaceutical Services Inc?

Shares in ReSearch Pharmaceutical Services Inc are currently trading at n/a, giving the company a market capitalisation of £n/a.

Where are ReSearch Pharmaceutical Services Inc shares listed? Where are ReSearch Pharmaceutical Services Inc shares listed?

Here are the trading details for ReSearch Pharmaceutical Services Inc:

Country of listing: United States
Exchange: NMQ
Ticker Symbol: RPSE
What kind of share is ReSearch Pharmaceutical Services Inc?

We were not able to load our ranking data for ReSearch Pharmaceutical Services Inc

Is there a ReSearch Pharmaceutical Services Inc share price forecast 2021?

We were not able to load any forecast data for ReSearch Pharmaceutical Services Inc.

How can I tell whether the ReSearch Pharmaceutical Services Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like ReSearch Pharmaceutical Services Inc. Over the past six months, the relative strength of its shares against the market has been %. At the current price of n/a, shares in ReSearch Pharmaceutical Services Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the ReSearch Pharmaceutical Services Inc PE Ratio?

We were not able to find PE ratio data for ReSearch Pharmaceutical Services Inc.

Who are the key directors of ReSearch Pharmaceutical Services Inc?

We were unable to find the directors for ReSearch Pharmaceutical Services Inc.

Who are the major shareholders of ReSearch Pharmaceutical Services Inc?

Here are the top five shareholders of ReSearch Pharmaceutical Services Inc based on the size of their shareholding:

Similar to RPSE
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.